Leadership
Beth established her contract research consulting company in 1999. Throughout her long career, she has provided operational oversight for early and late phase programs for Fortune 500 companies, including global submissions of blockbuster products. Beth has contributed to advancements in a multitude of therapeutic areas, including oncology, CNS, and clinical pharmacology.
In 2015, Beth expanded and renamed her company to Trialwise, a boutique CRO specializing in early phase studies. As the founder and president of Trialwise, Beth oversees a skilled team conducting clinical research for Phase 1 and 2 studies from planning through execution, and regularly consults with select private and government clients. Her expertise includes the complexities of data sources and their interface with clinical databases, data monitoring, the CRO landscape, and Good Clinical Practice.
Beth studied psychology and zoology at Brigham Young University and holds an MBA from the C.T. Bauer College of Business at the University of Houston.
In her more than 25 years of experience in clinical research, Beth Brinsdon has developed a valued, thorough, and nuanced understanding of investigational product development and what it takes to execute clinical trials.
President
Principal Clinical Research Consultant
Beth Brinsdon
With a career spanning more than 40 years as an architect and IT professional, Larry brings a unique perspective on constructing innovative technological solutions to support all aspects of the company’s operations.
Larry also maintains the role of Creative Director, managing Trialwise’s branding and external communications. Prior to his current position, he was a lecturer and visiting critic at the Rice University School of Architecture for almost two decades. He also ran the award-winning news website Swamplot.com for 12 years, and has been a contributing writer, editor, and photographer for national and local publications.
Larry holds an undergraduate degree from Yale University and a graduate degree from Rice University.
In his executive role, Larry guides the company's technology strategies and procedures.
VP, IT and Innovation
Larry Albert
In her role as the Director of Project Management, Peggy leads cross-functional projects with a level of thoroughness only an experienced professional from both the sponsor and site perspectives can deliver.
Early in her career, Peggy conducted research into the molecular biology of autoimmune disease and HSV infection. Later, her focus shifted to research and development of a novel enzyme replacement therapy for the treatment of Pompe disease, as well as a new molecular entity for the management of severe pain.
Peggy’s segue into clinical research came as development of a new chemical entity progressed to the initiation of clinical trials. She continued to advance in her career at several start-up biotechnology companies to Director of Project Management before joining Trialwise.
Peggy graduated with a BS in Biology from the University of Dallas.
Peggy brings more than 30 years of expertise in research, development, and project management to the Trialwise leadership team.
Director of Project Management
Peggy Tom
Liz began her career in academia as an oncology study/data coordinator at the University of Nebraska Medical Center where she had the opportunity to coordinate investigator-initiated trials as well as those driven by sponsor companies and cooperative study groups. After 5 years in a site role, Liz transitioned to work for a sponsor company and several contract research organizations with increasing levels of responsibility as both a CRA and study manager. In addition to oncology, Liz has continued to advance her career working across multiple therapeutic areas and phases of research.
Liz received her bachelor’s degree from the College of St. Mary and master’s degree in Public Administration from the University of Nebraska Omaha.
Liz is a member of the Association of Clinical Research Professionals (ACRP) and is a Certified Clinical Research Associate (CCRA).
Liz brings 28+ years of wide-ranging clinical research experience to the Trialwise leadership team as Principal CRA and CRA Manager.
Principal CRA and CRA Manager
Elizabeth (Liz) McAndrews
A biostatistician and statistical programmer, Noel has experience designing clinical trials while ensuring that processes within these functional areas are compliant with ICH guidelines. In more than 12 years of clinical research work, Noel has gained significant therapeutic area experience in Alzheimer’s, Cushing’s, Parkinson's, ALS, and phase 1 clinical pharmacology trials. Her areas of expertise include sample size calculations, randomization schedules, writing and executing statistical analysis plans, running and validating analyses, developing ad hoc analyses, writing statistical reports, and preparing manuscripts for publication, as well as such specialties as PK/EKG safety summary and reporting, drug liking/abuse potential studies, and longitudinal analysis of dental caries and dentures.
Noel has authored statistical analysis plans, programmed datasets to CDISC standards, generated TLFs, and everything in between. Her work in neurodegenerative diseases in collaboration with pharmaceutical companies, academic groups, and non-profit organizations has resulted in 38 publications. Noel has also provided biostatistics oversight for other CROs.
Noel graduated Magna Cum Laude from Brigham Young University with a bachelor’s degree in biostatistics and a master’s degree in statistics. She currently is pursuing a PhD in Computing with an Emphasis in Data Science at Boise State University, completing coursework in artificial intelligence, natural language processing, and machine learning.
Noel provides strategic leadership and subject matter expertise as Trialwise’s Director of Biostatistics.
Director of Biostatistics
Noel Ellison
Jennifer’s start at Trialwise marked a career switch after years of working in economic consulting and finance. Following initial assignments in project support and earning her certification, she advanced from CRA to Senior CRA. Jennifer also began supporting Trialwise’s data management efforts, and in 2023 she became the company’s Data Management manager. In addition to this ongoing role, Jennifer was appointed Trialwise’s Associate Director of Operations in 2023.
She has experience in clinical operations and monitoring for clinical pharmacology and phase 1 studies including first-in-human SAD/MAD, bioavailability, food effect, and drug-to-drug interaction (inhibitor and perpetrator) studies. Jennifer is also experienced in clinical research that involves hepatic and renal impairment, cardiac safety/thorough QTc, gastroenterology (ulcerative colitis, Crohn’s disease), infectious disease (HIV), musculoskeletal (osteoarthritis/pain), and ophthalmology (glaucoma).
Jennifer is a Certified Clinical Research Associate, a member of the Association for Clinical Research Professionals (ACRP), the Drug Information Association (DIA), and the Society for Clinical Data Management (SCDM). She holds a BA in Economics, having graduated magna cum laude from New York University.
Jennifer became employee number one at Trialwise in 2015. She now oversees the company’s business operations.
Associate Director, Operations
DM Manager
Jennifer Casey
From the moment she joined Trialwise in 2019, Kristin has been a star of the clinical operations and quality teams. She later became a founding member of the Trialwise Quality Committee. Kristin was promoted to Principal CRA in 2024 and since then has served in her current role as clinical operations manager.
Kristin began her clinical research career as a clinical research nurse at a Phase I unit. During the eight years she spent working directly for sites, Kristin held roles of increasing responsibility and learned how to work effectively with cross-functional study teams. Kristin is passionate about bringing a site's perspective to her work. She is a Licensed Practical Nurse and holds a Technical Diploma in Practical Nursing from Moraine Park Technical College in West Bend, Wisconsin.
Kristin brings more than 14 years of clinical research experience and a nurse’s perspective to the Trialwise leadership team.
Clinical Operations Manager
Principal CRA
Kristin Rittmann
Vanessa began her career in South Africa as a pharmacist. Thirteen years later she moved to New Zealand, where she expanded into clinical research in the pharmacy department of the largest hospital on the South Island. Responsible for the overall management of more than 100 phase 1 to 4 sponsored, collaborative group, and investigator-led clinical trials across multiple therapeutic areas, including oncology, hematology, and infectious diseases, Vanessa played a lead role in implementing efficient procedures for investigational product compounding and dispensing, as well as clinical trial training and support.
Vanessa transitioned to a CRA role when she moved to the U.S. and joined Trialwise in 2018. As she progressed from CRA to Senior CRA and (in May 2024) to Principal CRA, Vanessa developed expertise in unblinded monitoring, the development of pharmacy manuals and documentation, mock preparation assessments, and identifying opportunities to reduce complexity.
Vanessa holds a Bachelor of Pharmacy from the University of the Witwatersrand and a Master of Science, Clinical Research Management, from Arizona State University. She is a member of the Association of Clinical Research Professionals.